A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients Trial Phase 2 Completed April 24, 2024
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa Trial Phase 3 Completed April 24, 2024
The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients Trial Phase 2 Completed April 22, 2024
Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia Trial Phase 2 Completed April 22, 2024
Mixed Music Intervention on Sleep Disturbance in Patients With Parkinson's Disease Trial N/A Terminated April 21, 2024
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder Trial N/A Unknown April 18, 2024
Neural Correlates of Impulsivity in Idiopathic REM Sleep Behavior Disorder Trial N/A Unknown April 18, 2024
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Trial N/A Completed April 17, 2024
Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome Trial N/A Unknown April 16, 2024
Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders Trial N/A Completed April 15, 2024
AR Stimulation Effects on Gait, Anxiety, and Brain Connectivity in Parkinson's Disease Trial N/A Unknown April 15, 2024
Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3 Trial N/A Completed April 15, 2024
Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease Trial N/A Unknown April 15, 2024
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study Trial N/A Unknown April 14, 2024